Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

26,865 signal articles · 38 in last 24h · 129,346 total before filter · latest 1h ago
38last 24h
1274last 7d
203● bullish (7d)
131● bearish (7d)
206publishers
AllMacro290Earnings504M&A85Regulatory20Product13Analyst18
✕ clear all filtersticker: NVDASentiment:bullishneutralbearish✓ showing all (incl. clickbait)
NVIDIA (NVDA): The Best Quality Stock to Buy and Hold for the Next 5 Years
Insider Monkey113d agobullish
NVIDIA (NVDA): The Best Quality Stock to Buy and Hold for the Next 5 Years

NVIDIA Corporation (NASDAQ:NVDA) is one of the 10 Best Quality Stocks to Buy and Hold for the Next 5 Years. On May 6, 2026, Simulations Plus announced a technical collaboration with NVIDIA Corporation (NASDAQ:NVDA) focused on enabling GPU-accelerated simulation and AI-assisted workflows for computationally intensive modeling applications used throughout the drug development lifecycle. The collaboration […]

Reuters113d agoneutral
Thailand's SiamAI denies exporting US AI servers to China

Bangkok-based SiamAI said on Saturday it had ‌not exported AI servers to ‌China and that it complies with U.S. ​export and re-export control laws. • The firm has faced allegations of ‌circumventing exports of ⁠advanced chips from U.S. firms Super Micro Computer and ⁠Nvidia to China. • "SiamAI has not engaged in the export of AI ​servers to ​China," it said ​in a statement.

Palantir Tech (PLTR): 10 Best High Volume Stocks to Invest In According to Hedge Funds
Insider Monkey113d agoneutral
Palantir Tech (PLTR): 10 Best High Volume Stocks to Invest In According to Hedge Funds

Palantir Technologies Inc. (NASDAQ:PLTR) is one of the best high volume stocks to invest in according to hedge funds. On May 4, Palantir reported earnings for Q1 2026, achieving its highest-ever year-over-year growth rate of 85% with total revenue reaching $1.63 billion. This surge was fueled by the company’s US business, which more than doubled […]

NVIDIA Pushes AI Into Drug Development With Simulations Plus Collaboration
Simply Wall St.114d agoneutral
NVIDIA Pushes AI Into Drug Development With Simulations Plus Collaboration

NVIDIA (NasdaqGS:NVDA) has entered a new collaboration with Simulations Plus to apply GPU acceleration and AI-assisted workflows to drug development and quantitative systems pharmacology. The partnership focuses on speeding up complex modeling and simulation tasks that support earlier stage drug discovery and development decisions. This move extends NVIDIA's reach further into life sciences, complementing its existing presence in broader AI and data center computing. NVIDIA, with a recent...